ARCHIVES

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

This article is from The Cancer Letter archive.

Vol. 34 No. 36 | October 3, 2008

Download PDF Visit The Full Archive

Related Articles

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997

NIH Tells Grant Applicants One Resubmission Is Enough.

October 24, 2008

DCPC Concepts OKd Include Nurse Research Training

May 25, 1984